A comparison of cyclosporin versus azathioprine treatment in renal transplants in Edinburgh.
Three year graft survival rates were calculated for 66 patients on cyclosporin and prednisolone immuno-suppression and compared to survival rates for 73 patients on azathioprine and prednisolone. There was a temporary early advantage for the cyclosporin treatment group up to four months post transplant. There was no further significant difference between the two treatment groups with graft survival rate of 81.4% in cyclosporin and 76.7% in azathioprine group at three years post transplant. Fewer of the patients on cyclosporin had acute episodes of rejection. There was no significant difference in serum creatinine or urea at one year, but the haemoglobin level was higher in cyclosporin treated patients. Cyclosporin does not appear to have increased the survival rate significantly in our centre where there is already a high graft survival with azathioprine.
Notghi
A
A
Nuffield Transplant Unit, Western General Hospital, Edinburgh.
Dick
J
J
Smith
G
G
Anderton
J L
JL
Chisholm
G D
GD
D001379:Azathioprine / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D011239:Prednisolone / Q000627:therapeutic use*
D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine